Coherus Oncology (CHRS) FCF Margin Growth (1y) (2014 - 2026)
Coherus Oncology (CHRS) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Coherus Oncology |
199.14 Mn |
32.09 Mn |
8.50 Mn |
-6,827.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-6,827.00 |
| Dec 31, 2025 |
-59,031.00 |
| Sep 30, 2025 |
62,424.00 |
| Jun 30, 2025 |
329,082.00 |
| Mar 31, 2025 |
-651,362.00 |
| Dec 31, 2024 |
38,412.00 |
| Sep 30, 2024 |
-95,190.00 |
| Jun 30, 2024 |
103,511.00 |
| Mar 31, 2024 |
632,402.00 |
| Dec 31, 2023 |
20,641.00 |
| Sep 30, 2023 |
984.00 |
| Jun 30, 2023 |
1,820.00 |
| Mar 31, 2023 |
-12,144.00 |
| Dec 31, 2022 |
-14,864.00 |
| Sep 30, 2022 |
-9,896.00 |
| Jun 30, 2022 |
-8,396.00 |
| Mar 31, 2022 |
-9,240.00 |
| Dec 31, 2021 |
-10,109.00 |
| Sep 30, 2021 |
-2,354.00 |
| Jun 30, 2021 |
-4,330.00 |
